Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis
The cestode E. multilocularis causes the disease alveolar echinococcosis (AE) in humans. The continuously proliferating metacestode (larval stage) of the parasite infects mostly the liver and exhibits tumor-like growth. Current chemotherapeutical treatment options rely on benzimidazoles, which are r...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
15 June 2018
|
| In: |
International journal of parasitology. Drugs and drug resistance
Year: 2018, Volume: 8, Issue: 2, Pages: 331-340 |
| ISSN: | 2211-3207 |
| DOI: | 10.1016/j.ijpddr.2018.06.004 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1016/j.ijpddr.2018.06.004 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S2211320718300617 
|
| Author Notes: | Reto Rufener, Dominic Ritler, Jana Zielinski, Luca Dick, Emerson Teixeira da Silva, Adriele da Silva Araujo, Deborah Elisabeth Joekel, David Czock, Christine Goepfert, Adriana Marques Moraes, Marcus Vinicius Nora de Souza, Joachim Müller, Meike Mevissen, Andrew Hemphill, Britta Lundström-Stadelmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1663757534 | ||
| 003 | DE-627 | ||
| 005 | 20220816142804.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190429s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijpddr.2018.06.004 |2 doi | |
| 035 | |a (DE-627)1663757534 | ||
| 035 | |a (DE-599)KXP1663757534 | ||
| 035 | |a (OCoLC)1341212069 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Rufener, Reto |d 1990- |e VerfasserIn |0 (DE-588)1184851190 |0 (DE-627)1663757526 |4 aut | |
| 245 | 1 | 0 | |a Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis |c Reto Rufener, Dominic Ritler, Jana Zielinski, Luca Dick, Emerson Teixeira da Silva, Adriele da Silva Araujo, Deborah Elisabeth Joekel, David Czock, Christine Goepfert, Adriana Marques Moraes, Marcus Vinicius Nora de Souza, Joachim Müller, Meike Mevissen, Andrew Hemphill, Britta Lundström-Stadelmann |
| 264 | 1 | |c 15 June 2018 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 29.04.2019 | ||
| 500 | |a Im Titel ist "Echinococcus multilocularis" kursiv geschrieben | ||
| 520 | |a The cestode E. multilocularis causes the disease alveolar echinococcosis (AE) in humans. The continuously proliferating metacestode (larval stage) of the parasite infects mostly the liver and exhibits tumor-like growth. Current chemotherapeutical treatment options rely on benzimidazoles, which are rarely curative and have to be applied daily and life-long. This can result in considerable hepatotoxicity and thus treatment discontinuation. Therefore, novel drugs against AE are urgently needed. The anti-malarial mefloquine was previously shown to be active against E. multilocularis metacestodes in vitro, and in mice infected by intraperitoneal inoculation of metacestodes when administered at 100mg/kg by oral gavage twice a week for 12 weeks. In the present study, the same dosage regime was applied in mice infected via oral uptake of eggs representing the natural route of infection. After 12 weeks of treatment, the presence of parasite lesions was assessed in a liver squeeze chamber and by PCR, and a significantly reduced parasite load was found in mefloquine-treated animals. Assessment of mefloquine plasma concentrations by HPLC and modeling using a two-compartment pharmacokinetic model with first-order absorption showed that >90% of the expected steady-state levels (Cmin 1.15mg/L, Cmax 2.63mg/L) were reached. These levels are close to concentrations achieved in humans during long-term weekly dosage of 250mg (dose applied for malaria prophylaxis). In vitro structure-activity relationship analysis of mefloquine and ten derivatives revealed that none of the derivatives exhibited stronger activities than mefloquine. Activity was only observed, when the 2-piperidylmethanol group of mefloquine was replaced by an amino group-containing residue and when the trifluoromethyl residue on position 8 of the quinoline structure was present. This is in line with the anti-malarial activity of mefloquine and it implies that the mode of action in E. multilocularis might be similar to the one against malaria. | ||
| 650 | 4 | |a Alveolar echinococcosis | |
| 650 | 4 | |a Anti-malaria | |
| 650 | 4 | |a Drug repurposing | |
| 650 | 4 | |a HPLC | |
| 650 | 4 | |a Structure activity relationship | |
| 650 | 4 | |a Treatment | |
| 700 | 1 | |a Czock, David |e VerfasserIn |0 (DE-588)120971011 |0 (DE-627)705128253 |0 (DE-576)180276719 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of parasitology. Drugs and drug resistance |d Amsterdam [u.a.] : Elsevier, 2011 |g 8(2018), 2, Seite 331-340 |h Online-Ressource |w (DE-627)776855328 |w (DE-600)2751132-7 |w (DE-576)400002493 |x 2211-3207 |7 nnas |a Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis |
| 773 | 1 | 8 | |g volume:8 |g year:2018 |g number:2 |g pages:331-340 |g extent:10 |a Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpddr.2018.06.004 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S2211320718300617 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190429 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 120971011 |a Czock, David |m 120971011:Czock, David |d 910000 |d 910100 |e 910000PC120971011 |e 910100PC120971011 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 999 | |a KXP-PPN1663757534 |e 3456316925 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"Australian Society for Parasitology"}],"pubHistory":["1.2011 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["2211-3207"],"zdb":["2751132-7"],"eki":["776855328"]},"note":["Gesehen am 20.01.14"],"part":{"year":"2018","volume":"8","extent":"10","text":"8(2018), 2, Seite 331-340","issue":"2","pages":"331-340"},"name":{"displayForm":["sponsored by the Australian Society for Parasitology"]},"titleAlt":[{"title":"International Journal for Parasitology / Drugs and drug resistance"},{"title":"IJP drugs and drug resistance"}],"title":[{"title_sort":"International journal of parasitology","title":"International journal of parasitology","partname":"Drugs and drug resistance"}],"recId":"776855328","origin":[{"publisher":"Elsevier","dateIssuedDisp":"2011-","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"2011"}],"disp":"Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularisInternational journal of parasitology. Drugs and drug resistance","language":["eng"]}],"note":["Gesehen am 29.04.2019","Im Titel ist \"Echinococcus multilocularis\" kursiv geschrieben"],"id":{"eki":["1663757534"],"doi":["10.1016/j.ijpddr.2018.06.004"]},"physDesc":[{"extent":"10 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Reto Rufener, Dominic Ritler, Jana Zielinski, Luca Dick, Emerson Teixeira da Silva, Adriele da Silva Araujo, Deborah Elisabeth Joekel, David Czock, Christine Goepfert, Adriana Marques Moraes, Marcus Vinicius Nora de Souza, Joachim Müller, Meike Mevissen, Andrew Hemphill, Britta Lundström-Stadelmann"]},"person":[{"roleDisplay":"VerfasserIn","role":"aut","given":"Reto","family":"Rufener","display":"Rufener, Reto"},{"given":"David","role":"aut","family":"Czock","display":"Czock, David","roleDisplay":"VerfasserIn"}],"language":["eng"],"origin":[{"dateIssuedDisp":"15 June 2018","dateIssuedKey":"2018"}],"recId":"1663757534","title":[{"title":"Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis","title_sort":"Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis"}]} | ||
| SRT | |a RUFENERRETACTIVITYOF1520 | ||